XML 36 R23.htm IDEA: XBRL DOCUMENT v3.22.0.1
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Allowance for doubtful accounts $ 0 $ 0
Loss on impairment 0 0
Uncertain tax positions 0 0
Research and development cost 375,032 57,718
Cash equivalents $ 0 $ 0
Warrant [Member]    
Antidilutive Excluded from Computation of Earnings Per Share, Amount 12,596,000 1,363,350